Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued…
Mon, 23 Sep 2024 06:01:00 GMT The closing of the warrant exercise transaction is expected to ... stock issuable upon exercise of the new warrants. This press release shall not constitute an offer to sell or a solicitation ...
Fri, 20 Sep 2024 11:58:00 GMT 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ ... a short term of twenty-four months from the issuance date. This press release does not constitute an offer to sell or a solicitation of ...
Thu, 19 Sep 2024 17:00:00 GMT 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ ... covering the resale of the shares of common stock issuable upon the exercise of the new warrants. This press release does not constitute an offer ...
Thu, 12 Sep 2024 05:30:00 GMT WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants ...
Tue, 10 Sep 2024 02:46:00 GMT The Company has agreed to file a registration statement with the SEC covering the resale of the ordinary shares issuable upon exercise of the new warrants. This press release shall not constitute ...
